Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1986-7-25
|
| pubmed:abstractText |
Clinical and subclinical reinfection with varicella-zoster virus (VZV) in healthy persons may occur despite detectable neutralizing antibodies in serum. Subclinical reinfection is not uncommon, but clinical reinfection is rare. Therefore, detectable anti-VZV antibody correlates with a subclinical course after reinfection rather than with immunity to reinfection. Cell-mediated immunity (CMI) to VZV appears to be a better indicator of immunity. Skin testing may be a simple and reliable test for CMI, but this must be further evaluated.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0032-5473
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
61 Suppl 4
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
47-52
|
| pubmed:dateRevised |
2009-10-22
|
| pubmed:meshHeading |
pubmed-meshheading:3014477-Adult,
pubmed-meshheading:3014477-Age Factors,
pubmed-meshheading:3014477-Aged,
pubmed-meshheading:3014477-Antibodies, Viral,
pubmed-meshheading:3014477-Antibody-Dependent Cell Cytotoxicity,
pubmed-meshheading:3014477-Cytotoxicity, Immunologic,
pubmed-meshheading:3014477-Herpesvirus 3, Human,
pubmed-meshheading:3014477-Humans,
pubmed-meshheading:3014477-Immunity, Cellular,
pubmed-meshheading:3014477-Infant, Newborn
|
| pubmed:year |
1985
|
| pubmed:articleTitle |
Laboratory markers of immunity to varicella-zoster virus.
|
| pubmed:publicationType |
Journal Article
|